Using a new technology and computational method, researchers from Fred Hutch Cancer Center and The University of Texas MD ...
The firm will study its autologous cell therapy alone and in combination with Eisai's Lenvima in patients with hepatitis B-driven hepatocellular carcinoma.
Amezalpat has been granted FDA fast track designation as treatment for patients with hepatocellular carcinoma.
Researchers assessed the prognostic significance of older age and comorbidity burden on overall survival in patients with hepatocellular carcinoma.
The FDA has granted Fast Track designation to amezalpat (TPST-1120) for the treatment of patients with hepatocellular carcinoma.
A cancer expert has shared the five types of cancer which are considered the most "lethal", and claimed people diagnosed with ...
In the ALEXANDRA/IMpassion030 trial, Tecentriq (atezolizumab) added to postoperative chemotherapy was not found to improve ...
Investigator Award has been awarded to two surgeon-scientists at the National Cancer Centre Singapore (NCCS) to pursue novel research in liver cancer and head and neck cancers. Globally, liver cancer ...
Cancer cases in Jammu and Kashmir have increased by 50 percent at Paras Health Srinagar from September 2023 to January 2025, ...
Cancer remains a major health challenge in India, ranking as the third leading cause of death after infectious and ...
The lack of NHS funded testing for this type of cancer in Scotland means patients are denied targeted treatments unless they ...
Unlike the other more well-known type of liver cancer, hepatocellular carcinoma ... make sure that people who come after me ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results